APAC HIV Rapid Test Kits Market - Focused Insights 2023-2028

APAC HIV RAPID TEST KITS MARKET OVERVIEW

The APAC HIV rapid test kits market was valued at USD 418.81 million in 2022 and is projected to reach USD 487.70 million in 2028, with a CAGR of 2.57% during the forecast period. The market is witnessing significant growth due to the increasing prevalence of HIV infection and the increase in government support and funding for HIV management. ​Healthcare spending in APAC is high, favoring the APAC HIV rapid test kits market growth during the forecast period. 

MARKET DEFINITION  

The human immunodeficiency virus (HIV) rapid test kit is an in-vitro diagnostics (IVD) product that detects HIV exposure/presence in blood, oral fluid (saliva), and urine and yields results in 20-30 minutes. An HIV rapid self-test is a type of antibody test that can be used at home or in a private location. HIV rapid test kit is one of the convenient and widely accepted IVD products used for HIV diagnosis and preventive measures that are used in a home or any private place of the Individual. Three technologies are used to develop HIV rapid test kits that reduce the burden of laboratory visits and requirements. 

MARKET DRIVERS 

Increase in Targeted Patient Population: In 2021, the WHO estimated that around 38.4 million people were living with HIV infection across the world, with the APAC region reporting approximately 6 million. About 13–15% of the HIV-infected population is aware of their status and requires testing. According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), an estimated 260,000 new HIV infections were reported in the APAC region in 2021. 

Increasing Resources Availability and Fundings for HIV Management: The UNAIDS Programme Coordination Board and the government (UNAIDS-associated countries governments) have begun to invest in ending the HIV/AIDS epidemic worldwide, including in the United States. Hence, the increasing resource availability and the growing global fund for HIV infection management have accelerated the use of HIV care treatments, driving the adoption of HIV rapid test kits. 

APAC HIV RAPID TEST KITS MARKET INSIGHTS

• The APAC HIV rapid test kits market is experiencing healthy growth due to the awareness of the HIV status, the rise in the target patient population, and the rise in government support & funding for HIV management. 
• The lateral flow immunoassay segment is growing with the fastest CAGR of 2.66% during the forecast period. Lateral flow tests are among the most common rapid diagnostic tests used in the market, and millions of these tests are performed each year. They have the potential to support near-person testing and decentralized management of a range of clinically important diseases, including HIV, making them convenient for end-users and affordable for health systems. They are the quickest methods that deliver results in minimum time after loading the sample, thus driving the market. 
• Based on sample type, the blood sample type segment accounted for a major market share in the APAC HIV rapid test kits market and dominated the other segments. These test kits work based on the principle that antibodies produced by an HIV-infected person will react in an Ag-Ab reaction when they accidentally meet the antigen from the virus. Blood sample-based HIV quick test kits are highly recommended by medical professionals due to their potential to carry HIV antibodies in high proportion. 
• The offline segment dominates the distribution channels of the APAC HIV rapid test kits market share. Consumers in several developing countries choose medical pharmacies as their first center to purchase HIV rapid test kits. Easy access and availability for buyers are the major factors driving the sale of offline channels. Easy access and availability, along with the convenience of buyers, are the major factors that cause significant sales through offline channels. 

REGIONAL ANALYSIS  

Vietnam is the fastest-growing region in the APAC HIV rapid test kits market. The growth of the HIV rapid test kits market in Vietnam can be attributed to the rise in the target patient population, high acceptance of HIV rapid test kits, increased awareness of HIV infection, and a surge in government support. 

VENDOR LANDSCAPE  

The APAC HIV rapid test kits market report contains exclusive data on 25 vendors. Abbott, OraSure Technologies, Bio-Rad Laboratories, ChemBio Diagnostics, and Biomerieux are the leading players in the market. The market offers tremendous growth opportunities for existing and future/emerging players because of the high prevalence of HIV and awareness about the HIV status of the population.